Outpatient Surgery Magazine

ORX Awards and the Winners Are ... - September 2014 - Subscribe to Outpatient Surgery Magazine

Outpatient Surgery Magazine, providing current information on Surgical Services, Surgical Facility Administration, Outpatient Surgery News and Trends, OR Excellence and more.

Issue link: http://outpatientsurgery.uberflip.com/i/378604

Contents of this Issue

Navigation

Page 32 of 170

Manufacturer Dantrolene dose per vial Number of vials for initial dose* Water to reconstitute 1 vial Vials required to stock Price Shelf life US WorldMeds Par Pharmaceutical Eagle Pharmaceuticals 20 mg 20 mg 250 mg 8 vials (480 mL) 8 vials (480 mL) 1 vial (5 mL) 60 mL 60 mL 5 mL 36 36 3 $3,000 $3,000 $6,900 3 years 3 years 2 years Your Guide to MH Antidotes Ryanodex is the first new drug in more than 7 years for MH, a life- threatening complica- tion of anesthesia. Here's how Ryanodex compares to long- standing dantrolene formulations Revonto and Dantrium. Revonto Dantrium Ryanodex * Assumes a 140-lb patient at 2.5 mg/kg. (Par Pharmaceutical). Regardless of which antidote you stock, chances are you'll never use it. The overwhelming odds are that you'll never experience an episode of MH, an inherited and potentially fatal disorder triggered by certain anesthesia agents in genetically susceptible individuals. Experts say you should use expired product in MH-preparedness staff drills. — Jim Burger S E P T E M B E R 2 0 1 4 | O U T P AT I E N T S U R G E R Y M A G A Z I N E O N L I N E 3 3

Articles in this issue

Archives of this issue

view archives of Outpatient Surgery Magazine - ORX Awards and the Winners Are ... - September 2014 - Subscribe to Outpatient Surgery Magazine